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Abstract 1 
Introduction: Pulmonary Rehabilitation (PR) is a core component of the management of patients with 2 
moderate-to-very-severe Chronic Obstructive Pulmonary Disease (COPD). However, as impairments 3 
in quadriceps muscle strength and health-related quality of life (HRQL) are already present in patients 4 
with mild COPD, there is a need to investigate if PR could also be beneficial to these patients. Thus, 5 
this study assessed the impact of PR in patients with mild COPD.  6 
Methods: A quasi-experimental study was conducted. Twenty-six participants (67.8±10.3yrs; forced 7 
expiratory volume in 1 second 86.2±7.9% predicted) enrolled in a 12-week PR program with exercise 8 
training and psychoeducation. Lung function was assessed with spirometry, dyspnea with the 9 
Modified British Medical Research Council questionnaire, functional balance with the Timed Up and 10 
Go test; muscle strength with the 10 repetition maximum testing; exercise tolerance with the 6-minute 11 
walking test; emotional state with the Depression, Anxiety and Stress Scales and HRQL with the St. 12 
George’s Respiratory Questionnaire (SGRQ).  13 
Results: Significant effects were observed on participants’ dyspnea (p=0.003; effect size-ES=0.7), 14 
functional balance (p<0.001; ES=0.8), shoulder flexors/knee extensors strength (p<0.001; ES=1.2-15 
1.3) and exercise tolerance (p<0.001; ES=0.5). With the exception of the SGRQ impact score, the 16 
symptoms (p<0.001; ES=0.6), activities (p=0.02; ES=0.4) and total (p=0.005; ES=0.3) scores 17 
improved significantly after PR. The PR program had no significant effect on participants’ lung 18 
function and emotional state.  19 
Conclusions:  Patients with mild COPD benefit from PR and could therefore be routinely included in 20 
these programs. Studies with more robust designs and with long-term follow-ups are needed to inform 21 
guidelines for PR in mild COPD. 22 
 23 
Key Words: Chronic obstructive pulmonary disease; pulmonary rehabilitation; early medical 24 
intervention.25 
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Introduction 1 
Pulmonary rehabilitation (PR) is “a comprehensive intervention (…) that include, but are not limited to, 2 
exercise training, education, and behavior change, designed to improve the physical and 3 
psychological condition of people with chronic respiratory disease” 
1
. A meta-analysis demonstrated 4 
that PR is effective in improving dyspnea and health-related quality of life (HRQL) in patients with 5 
moderate-to-very-severe Chronic Obstructive Pulmonary Disease (COPD)
2
 and thus, it is currently 6 
recognized as a core component of the management of these patients
3
. 7 
Recent evidence showed that quadriceps muscle strength and HRQL are already impaired in patients 8 
with mild COPD (post-bronchodilator forced expiratory volume in 1 second-FEV1/forced vital capacity 9 
ratio of <0.7 and an FEV1>80% of the predicted
4
)
5
. Therefore, as stated in the American Thoracic 10 
Society/ European Respiratory Society statement on PR, there is a need to investigate the potential of 11 
PR in these patients
1
.  12 
A preliminary study from Riario-Sforza et al. found that, after a 6-week outpatient PR program, 13 
patients with mild COPD improved their exercise tolerance
6
. However, the effects of PR on other 14 
health domains are still unestablished. Thus, this study aimed to assess the impact of PR on lung 15 
function, dyspnea, functional balance, muscle strength, exercise tolerance, emotional state and HRQL 16 
of patients with mild COPD. In line with research conducted in more severe grades of COPD, it is 17 
hypothesized that patients with mild COPD will also benefit from PR and that these benefits will be 18 
observed in different health domains. 19 
Methods 20 
Design and Participants 21 
A quasi-experimental one group pretest-posttest design was used. Outpatients with mild COPD were 22 
recruited from two primary care centers. Inclusion criteria were diagnosis of mild COPD according to 23 
the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria (post-bronchodilator 24 
FEV1/forced vital capacity ratio of <0.7 and an FEV1>80% of the predicted)
4
, age ≥18 years old and 25 
clinical stability for 1 month prior to the study (i.e., no hospital admissions or exacerbations as defined 26 
by the GOLD
4
). Patients were excluded if they presented severe psychiatric, neurologic or 27 
musculoskeletal conditions
7
 and/or unstable cardiovascular disease that could interfere with their 28 
performance during the exercise training sessions. The study received full approval from the 29 
Institutional Ethics Committee and written informed consent was obtained before data collection.  30 
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Intervention 1 
A 12-week PR program with exercise training (3 sessions per week, 60 minutes each) and 2 
psychoeducation (1 session per week, 90 minutes) was conducted. The exercise training sessions 3 
comprised by:  4 
i. A warm up and a cool down period including range-of-motion, stretching, low-intensity aerobic 5 
exercises and breathing techniques (5-10 min)
8
. 6 
ii. Endurance training (walking) at 60-80% of the average speed achieved during the 6-minute 7 
walking test (6MWT) (20 min)
9
. The training intensity was adjusted according to patient’s 8 
symptoms on the Modified Borg scale (a rating of 4 to 6 on perceived dyspnea/fatigue was an 9 
indicator of adequate training intensity)
1
. 10 
iii. Strength training including 7 exercises (2 sets of 10 repetitions) of the major upper and lower 11 
limbs muscle groups using free weights and ankle weights (15 min)
10
. The amount of weight 12 
was between 50-85% of the 10 repetition maximum (10-RM)
1
. The training progression was 13 
based on the two-for-two rule (load was increased when two additional repetitions could be 14 
performed on two consecutive sessions)
10
 and on patient’s symptoms (Modified Borg Scale 4-15 
6)
1
. 16 
iv. Balance training consisting of static and dynamic exercises using upright positions (5 min).  17 
In the psychoeducation component the main themes addressed were: information about COPD; 18 
medication management; healthy lifestyles; falls and their pre ention; emotion-management 19 
strategies and community resources. 20 
Data Collection 21 
Socio-demographic and clinical (smoking habits, body mass index, exacerbations in the past 3 22 
months) data were obtained to characterize the sample. Lung function, dyspnea, functional balance, 23 
muscle strength, exercise tolerance, emotional state and HRQL were collected before and after the 24 
PR program. All questionnaires/tests were administered in a standardized order. 25 
Outcome Measures 26 
Lung function. A spirometric test, using a portable spirometer (MicroLab 3500, CareFusion, Kent, 27 
UK), was performed according to standardized guidelines
11
. 28 
Dyspnea. Patients reported their activities limitation resulting from dyspnea by selecting the 29 
statement from the Modified British Medical Research Council questionnaire that best described their 30 
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limitation
4
. The questionnaire comprises five grades (statements) in a scale from 0 to 4, with higher 1 
grades indicating greater perceived respiratory limitation. This scale is simple and valid to 2 
characterize the impact that dyspnea has on activities of patients with COPD
4
 and variations of 1 point 3 
indicate a perceived clinical improvement
12
. 4 
Functional balance. The Timed Up and Go test was used to assess functional balance
13
. The test 5 
requires the patient to rise from a standard chair, walk 3 meters, turn around, walk back to the chair 6 
and sit down. Patients were instructed to walk quickly, but as safely as possible. Two tests were 7 
performed and the best performance was considered.  8 
Muscle strength. The muscle strength of the shoulder flexors and of the knee extensors of the 9 
dominant limbs was assessed using the 10-RM with ankle and free weights. In patients with COPD, 10 
the completion of 1-RM testing may not be advisable or safe
14
, thus multiple RM, such as 10-RM, 11 
have been used
15
. The 10-RM testing was considered the maximum amount of weight that could be 12 
moved through the full range of motion 10 times, with the proper technique and without compensatory 13 
movements
10
.  14 
Exercise tolerance. Exercise tolerance was measured using the 6MWT. The measurement 15 
properties of this test are well established in COPD and it has showed similar peak rate of oxygen 16 
uptake and heart rate as an incremental cycle ergometer test
16
. Two tests were performed according 17 
to the protocol described by the American Thoracic Society
17
 and the best performance was 18 
considered. The minimal important difference (MID) for the 6MWT is 25 meters in patients with 19 
COPD
18
. 20 
Emotional state. The Depression, Anxiety, Stress Scales (DASS) measure the negative emotional 21 
states of depression, anxiety and stress
19
. Each sub-scale has seven items and the participant is 22 
asked to use a 4-point (from 0 to 3) severity scale to rate the extent to which they have experienced 23 
each state over the past week. Internal consistency has been shown to be acceptable for all three 24 
scales (Cronbach’s alphas between .82 and .93)
20
. Consistent with convention, all DASS-21 scores 25 
were doubled to facilitate comparison with previous research and norms established using the DASS-26 
42. The maximum score of the DASS-42 is 42 in each of depression, anxiety and stress scales and 27 
higher scores indicate high levels of emotional distress. 28 
Health-related quality of life. The St. George’s Respiratory Questionnaire (SGRQ) is a disease-29 
specific instrument designed to measure quality of life in patients with chronic lung disease
21
. The 30 
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questionnaire has three domains: symptoms, activities and impact. SGRQ presented high internal 1 
consistency with Cronbach’s alphas >.7 in the sub-domains and >.9 in the overall questionnaire
22
. For 2 
each domain and for the total questionnaire, score ranges from 0 (no impairment) to 100 (maximum 3 
impairment). A change of 4 units is considered clinically relevant
21
. 4 
Statistical Analysis 5 
Using 6MWT data from the study of Riario-Sforza et al. (effect size=0.88)
6
, a sample size estimation 6 
with 95% power (α=0.05) was performed. This power analysis determined that a statistically 7 
significant difference in 6MWT after a PR program would be detected with 19 subjects. As PR 8 
programs have considerable dropouts, varying between 20‐40%
23, 24
, 30 patients were recruited.  9 
Descriptive statistics were used to describe the sample. For each outcome measure, the normality of 10 
data was investigated with the Shapiro–Wilk test. Paired t-tests for normally distributed data and 11 
Wilcoxon signed-rank tests for ordinal/non-normally distributed data were used to compare pre- and 12 
post-PR variables. The level of significance was set at 0.05. These analyzes were performed using 13 
IBM SPSS Statistics version 20.0 (IBM Corporation, Armonk, NY, USA). 14 
Statistical analysis was completed with the estimation of effect sizes indices, which evaluate the 15 
magnitude of treatment effect
25
. The formula Cohen's dz was used (mean change score divided by 16 
the standard deviation of change), as this is the effect size index recommended for matched pairs
26
. 17 
Cohen’s dz for each outcome measure was calculated using the G*Power 3 software (University 18 
Düsseldorf, Germany) and was interpreted as a small (≥0.2), medium (≥0.5) or large (≥0.8) effect
27
.  19 
Results 20 
Thirty patients enrolled in the study, however 4 (13.3%) dropped-out due to overlap between the 21 
program schedule and professional activities (n=1), relocation (n=1), respiratory exacerbation (n=1) 22 
and no reason given (n=1). Therefore, 26 participants (16 males; age 67.8±10.3 years old) completed 23 
the study. Table 1 provides the characteristics of the participants. 24 
(insert table 1 about here) 25 
The PR program had no effect on lung function (pre 83.8% predicted vs. post 84.1% predicted; 
26 
p=0.73) (table 2). A reduction in participants’ dyspnea was observed (pre median [interquarlile range] 
27 
1[1,2] vs. post 1[0,1]; p=0.003; ES=0.7), with more than half of participants (n=16; 61.5%) presenting 
28 
a mMRC variation >1. Significant improvements were also verified on functional balance (pre 7.8s vs. 
29 
6.7s; p<0.001), muscle strength (shoulder flexors pre 2.3kg vs. post 3.6kg; knee extensors pre 4.1kg 
30 
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vs. post 6.7kg; p<0.001) and exercise tolerance (pre 432m vs. post 464m; p<0.001), with medium and 
1 
large effects sizes (from 0.5 to 1.3) (table 2). However, no differences were found for the emotional 
2 
states of depression (pre median 6 vs. post 4; p=0.65), anxiety (pre median 6 vs. post 5; p=0.82) and 
3 
stress (pre median 10 vs. post 8; p=0.63). The SGRQ total score (pre 31.3 vs. post 25; p=0.005; 
4 
ES=0.3), the SGRQ symptoms score (pre 46.3 vs. post 34.7; p<0.001; ES=0.6) and the SGRQ 
5 
activities score (pre 44 vs. post 34.8; p=0.02; ES=0.4) improved significantly after PR, reaching the 
6 
MID (4 units)
21
. However, there was no significant improvement on the SGRQ impact score (pre 19.4 
7 
vs. post 16.3; p=0.14). 
8 
(insert table 2 about here) 9 
Discussion 10 
According to our knowledge, this was the first study to investigate the effects of PR on different health 11 
domains in patients with mild COPD. The main finding was that a 12-week PR program was effective 12 
in improving patients’ dyspnea, functional balance, muscle strength, exercise tolerance and HRQL. 13 
A perceived clinical improvement on dyspnea was observed in >50% of patients, in line with the 14 
existing evidence on the benefits of PR in patients with moderate-to-very-severe COPD
12
. This result 15 
demonstrates that patients with mild COPD already experience restrictions in their daily life due to 16 
dyspnea and that PR has the potential to reverse this situation. Regarding the effect of the program 17 
on patients’ functional balance, a change of -1.1±1 seconds on TUG score was found. This change is 18 
lower than that obtained by Beauchamp et al. (-1.5±2.4 seconds), which examined the effect of a 19 
standard PR program on balance of patients with more severe COPD grades (mean FEV1 20 
46.3±22.3%)
28
. However, this result is not surprising since patients with mild COPD had better 21 
baseline scores compared with patients included in the previous mentioned study, and thus less 22 
potential to further improve their functional balance was expected. Increases of 56.5% on shoulder 23 
flexors and of 63.4% on knee extensors muscle strength were verified. These results are difficult to 24 
interpret in the absence of published MID values for the 10-RM. Nevertheless, the percentage 25 
changes found are similar to previous research (a 56.3% increase in chest pull exercise and 88.2% in 26 
leg extension)
29
. 27 
The improvement in the distance walked after PR was about 32 meters. Considering that 25 meters is 28 
the MID for the 6MWT in patients with COPD
18
, it could be assumed that this study achieved the 29 
clinically important effect. However, this MID was established based on a sample of patients with a 30 
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wide range of disease severity and may not represent a clinically important effect for patients with 1 
mild COPD. Future studies should determine the MID for the 6MWT in patients with mild COPD to 2 
contribute for clinical decision-making in this COPD population. 3 
An improvement in the SGRQ total score of about 6 units was also observed, exceeding the 4 units 4 
considered clinically relevant
21
. This result demonstrates that HRQL in patients with mild COPD, even 5 
if not severely affected (baseline scores of 31.3 in 100), can be improved with PR. Contrary to the 6 
symptoms and activities domains, the impact domain was not significantly different after PR. Patients 7 
with mild COPD might not experience yet relevant disturbances in social and psychological 8 
functioning in their daily life, demonstrated by the low impact scores found at baseline (19.4 in 100)
5
, 9 
and therefore this domain had less potential to be improved. 10 
The PR program had no effect on lung function, which is in accordance with the short-term effects of 11 
PR
30
. However, a longitudinal study with patients with moderate-to-severe COPD showed that, after 12 
three years, the decline in FEV1 was significantly lower in the PR group compared to the standard 13 
care group
31
. The potential of PR in delaying the decline of lung function should therefore be 14 
examined in patients with mild COPD as well. Patients’ emotional state also did not improve after the 15 
intervention. However, significant benefits in the emotional function of patients with moderate-to-very-16 
severe COPD after PR programs have been described
2
. Since patients’ baseline scores on DASS 17 
were only slightly higher than normative values (depression 6 vs. 2; anxiety 6 vs. 2; stress 10 vs. 8)
20
, 18 
one possible reason for this result may be that patients with mild COPD may not yet experience 19 
significant emotional distress. 20 
The overall findings suggest that PR is effective in improving dyspnea, functional balance, muscle 21 
strength, exercise tolerance and HRQL in patients with mild COPD. Thus, the critical question for 22 
future studies should move from “should patients with mild COPD be integrated in PR?” to “how 23 
should PR be delivered to these patients?”. Since patients are not referred to hospital-based PR 24 
programs until they have advanced COPD
1
, less expensive and complex PR programs available at 25 
primary care centers could be a promising strategy to deliver PR to patients with mild COPD. These 26 
programs, through the exercise training component, would maintain patients at higher levels of 27 
function. Exercise programs in fitness centers with adequate supervision by trained professionals 28 
would probably accomplish the same physical benefits of these simple PR programs, with fewer 29 
costs; however these programs do not address patients’ education and behavior change needs. The 30 
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psychoeducation component of PR through collaborative self-management strategies, increases 1 
patients’ knowledge and skills, key aspects to optimally manage their disease. Therefore, the potential 2 
of primary-care based PR to modify the COPD trajectory in patients at earlier grades should be 3 
investigated in future COPD research. 4 
This study has some limitations that need to be acknowledged. The absence of a control group is a 5 
limitation of this exploratory study. However, as no research has been conducted on this topic, this 6 
limitation does not appear to remove the validity and importance of the results found. In future studies, 7 
a control group with patients with similar socio-demographic and clinical characteristics should be 8 
included. A small sample size was estimated to be sufficient to detect statistically significant 9 
differences in the 6MWT, however a larger sample would probably contribute to detect statistically 10 
significant differences in the other outcome measures collected, such as DASS and SGRQ impact 11 
score. Nonetheless, data from these outcome measures may inform the estimation of sample sizes in 12 
future studies. Moreover, the evaluators in this study were the same health professionals that 13 
delivered the PR program, which may have influenced the way that outcome measures were 14 
assessed. Due to the cross-sectional design, the long-term effects of PR on mild COPD could not be 15 
established. Blind randomized control trials with long-term follow-ups are therefore needed. 16 
Conclusion 17 
The PR program was effective in improving dyspnea, functional balance, muscle strength, exercise 18 
tolerance and HRQL of patients with mild COPD, suggesting that these patients would benefit of 19 
being routinely included in PR programs. Studies with more robust designs and with long-term follow-20 
ups are needed to inform guidelines for PR in mild COPD. 21 
 22 
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Abstract 1 
Introduction: Pulmonary Rehabilitation (PR) is a core component of the management of patients with 2 
moderate-to-very-severe Chronic Obstructive Pulmonary Disease (COPD). However, as impairments 3 
in quadriceps muscle strength and health-related quality of life (HRQL) are already present in patients 4 
with mild COPD, there is a need to investigate if PR could also be beneficial to these patients. Thus, 5 
this study assessed the impact of PR in patients with mild COPD.  6 
Methods: A quasi-experimental study was conducted. Twenty-six participants (67.8±10.3yrs; forced 7 
expiratory volume in 1 second 86.2±7.9% predicted) enrolled in a 12-week PR program with exercise 8 
training and psychoeducation. Lung function was assessed with spirometry, dyspnea with the 9 
Modified British Medical Research Council questionnaire, functional balance with the Timed Up and 10 
Go test; muscle strength with the 10 repetition maximum testing; exercise tolerance with the 6-minute 11 
walking test; emotional state with the Depression, Anxiety and Stress Scales and HRQL with the St. 12 
George’s Respiratory Questionnaire (SGRQ).  13 
Results: Significant effects were observed on participants’ dyspnea (p=0.003; effect size-ES=0.7), 14 
functional balance (p<0.001; ES=0.8), shoulder flexors/knee extensors strength (p<0.001; ES=1.2-15 
1.3) and exercise tolerance (p<0.001; ES=0.5). With the exception of the SGRQ impact score, the 16 
symptoms (p<0.001; ES=0.6), activities (p=0.02; ES=0.4) and total (p=0.005; ES=0.3) scores 17 
improved significantly after PR. The PR program had no significant effect on participants’ lung 18 
function and emotional state.  19 
Conclusions:  Patients with mild COPD benefit from PR and could therefore be routinely included in 20 
these programs. Studies with more robust designs and with long-term follow-ups are needed to inform 21 
guidelines for PR in mild COPD. 22 
 23 
Key Words: Chronic obstructive pulmonary disease; pulmonary rehabilitation; early medical 24 
intervention.25 
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Introduction 1 
Pulmonary rehabilitation (PR) is “a comprehensive intervention (…) that include, but are not limited to, 2 
exercise training, education, and behavior change, designed to improve the physical and 3 
psychological condition of people with chronic respiratory disease” 
1
. A meta-analysis demonstrated 4 
that PR is effective in improving dyspnea and health-related quality of life (HRQL) in patients with 5 
moderate-to-very-severe Chronic Obstructive Pulmonary Disease (COPD)
2
 and thus, it is currently 6 
recognized as a core component of the management of these patients
3
. 7 
Recent evidence showed that quadriceps muscle strength and HRQL are already impaired in patients 8 
with mild COPD (post-bronchodilator forced expiratory volume in 1 second-FEV1/forced vital capacity 9 
ratio of <0.7 and an FEV1>80% of the predicted
4
)
5
. Therefore, as stated in the American Thoracic 10 
Society/ European Respiratory Society statement on PR, there is a need to investigate the potential of 11 
PR in these patients
1
.  12 
A preliminary study from Riario-Sforza et al. found that, after a 6-week outpatient PR program, 13 
patients with mild COPD improved their exercise tolerance
6
. However, the effects of PR on other 14 
health domains are still unestablished. Thus, this study aimed to assess the impact of PR on lung 15 
function, dyspnea, functional balance, muscle strength, exercise tolerance, emotional state and HRQL 16 
of patients with mild COPD. In line with research conducted in more severe grades of COPD, it is 17 
hypothesized that patients with mild COPD will also benefit from PR and that these benefits will be 18 
observed in different health domains. 19 
Methods 20 
Design and Participants 21 
A quasi-experimental one group pretest-posttest design was used. Outpatients with mild COPD were 22 
recruited from two primary care centers. Inclusion criteria were diagnosis of mild COPD according to 23 
the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria (post-bronchodilator 24 
FEV1/forced vital capacity ratio of <0.7 and an FEV1>80% of the predicted)
4
, age ≥18 years old and 25 
clinical stability for 1 month prior to the study (i.e., no hospital admissions or exacerbations as defined 26 
by the GOLD
4
). Patients were excluded if they presented severe psychiatric, neurologic or 27 
musculoskeletal conditions
7
 and/or unstable cardiovascular disease that could interfere with their 28 
performance during the exercise training sessions. The study received full approval from the 29 
Institutional Ethics Committee and written informed consent was obtained before data collection.  30 
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Intervention 1 
A 12-week PR program with exercise training (3 sessions per week, 60 minutes each) and 2 
psychoeducation (1 session per week, 90 minutes) was conducted. The exercise training sessions 3 
comprised by:  4 
i. A warm up and a cool down period including range-of-motion, stretching, low-intensity aerobic 5 
exercises and breathing techniques (5-10 min)
8
. 6 
ii. Endurance training (walking) at 60-80% of the average speed achieved during the 6-minute 7 
walking test (6MWT) (20 min)
9
. The training intensity was adjusted according to patient’s 8 
symptoms on the Modified Borg scale (a rating of 4 to 6 on perceived dyspnea/fatigue was an 9 
indicator of adequate training intensity)
1
. 10 
iii. Strength training including 7 exercises (2 sets of 10 repetitions) of the major upper and lower 11 
limbs muscle groups using free weights and ankle weights (15 min)
10
. The amount of weight 12 
was between 50-85% of the 10 repetition maximum (10-RM)
1
. The training progression was 13 
based on the two-for-two rule (load was increased when two additional repetitions could be 14 
performed on two consecutive sessions)
10
 and on patient’s symptoms (Modified Borg Scale 4-15 
6)
1
. 16 
iv. Balance training consisting of static and dynamic exercises using upright positions (5 min).  17 
In the psychoeducation component the main themes addressed were: information about COPD; 18 
medication management; healthy lifestyles; falls and their pre ention; emotion-management 19 
strategies and community resources. 20 
Data Collection 21 
Socio-demographic and clinical (smoking habits, body mass index, exacerbations in the past 3 22 
months) data were obtained to characterize the sample. Lung function, dyspnea, functional balance, 23 
muscle strength, exercise tolerance, emotional state and HRQL were collected before and after the 24 
PR program. All questionnaires/tests were administered in a standardized order. 25 
Outcome Measures 26 
Lung function. A spirometric test, using a portable spirometer (MicroLab 3500, CareFusion, Kent, 27 
UK), was performed according to standardized guidelines
11
. 28 
Dyspnea. Patients reported their activities limitation resulting from dyspnea by selecting the 29 
statement from the Modified British Medical Research Council questionnaire that best described their 30 
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limitation
4
. The questionnaire comprises five grades (statements) in a scale from 0 to 4, with higher 1 
grades indicating greater perceived respiratory limitation. This scale is simple and valid to 2 
characterize the impact that dyspnea has on activities of patients with COPD
4
 and variations of 1 point 3 
indicate a perceived clinical improvement
12
. 4 
Functional balance. The Timed Up and Go test was used to assess functional balance
13
. The test 5 
requires the patient to rise from a standard chair, walk 3 meters, turn around, walk back to the chair 6 
and sit down. Patients were instructed to walk quickly, but as safely as possible. Two tests were 7 
performed and the best performance was considered.  8 
Muscle strength. The muscle strength of the shoulder flexors and of the knee extensors of the 9 
dominant limbs was assessed using the 10-RM with ankle and free weights. In patients with COPD, 10 
the completion of 1-RM testing may not be advisable or safe
14
, thus multiple RM, such as 10-RM, 11 
have been used
15
. The 10-RM testing was considered the maximum amount of weight that could be 12 
moved through the full range of motion 10 times, with the proper technique and without compensatory 13 
movements
10
.  14 
Exercise tolerance. Exercise tolerance was measured using the 6MWT. The measurement 15 
properties of this test are well established in COPD and it has showed similar peak rate of oxygen 16 
uptake and heart rate as an incremental cycle ergometer test
16
. Two tests were performed according 17 
to the protocol described by the American Thoracic Society
17
 and the best performance was 18 
considered. The minimal important difference (MID) for the 6MWT is 25 meters in patients with 19 
COPD
18
. 20 
Emotional state. The Depression, Anxiety, Stress Scales (DASS) measure the negative emotional 21 
states of depression, anxiety and stress
19
. Each sub-scale has seven items and the participant is 22 
asked to use a 4-point (from 0 to 3) severity scale to rate the extent to which they have experienced 23 
each state over the past week. Internal consistency has been shown to be acceptable for all three 24 
scales (Cronbach’s alphas between .82 and .93)
20
. Consistent with convention, all DASS-21 scores 25 
were doubled to facilitate comparison with previous research and norms established using the DASS-26 
42. The maximum score of the DASS-42 is 42 in each of depression, anxiety and stress scales and 27 
higher scores indicate high levels of emotional distress. 28 
Health-related quality of life. The St. George’s Respiratory Questionnaire (SGRQ) is a disease-29 
specific instrument designed to measure quality of life in patients with chronic lung disease
21
. The 30 
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questionnaire has three domains: symptoms, activities and impact. SGRQ presented high internal 1 
consistency with Cronbach’s alphas >.7 in the sub-domains and >.9 in the overall questionnaire
22
. For 2 
each domain and for the total questionnaire, score ranges from 0 (no impairment) to 100 (maximum 3 
impairment). A change of 4 units is considered clinically relevant
21
. 4 
Statistical Analysis 5 
Using 6MWT data from the study of Riario-Sforza et al. (effect size=0.88)
6
, a sample size estimation 6 
with 95% power (α=0.05) was performed. This power analysis determined that a statistically 7 
significant difference in 6MWT after a PR program would be detected with 19 subjects. As PR 8 
programs have considerable dropouts, varying between 20‐40%
23, 24
, 30 patients were recruited.  9 
Descriptive statistics were used to describe the sample. For each outcome measure, the normality of 10 
data was investigated with the Shapiro–Wilk test. Paired t-tests for normally distributed data and 11 
Wilcoxon signed-rank tests for ordinal/non-normally distributed data were used to compare pre- and 12 
post-PR variables. The level of significance was set at 0.05. These analyzes were performed using 13 
IBM SPSS Statistics version 20.0 (IBM Corporation, Armonk, NY, USA). 14 
Statistical analysis was completed with the estimation of effect sizes indices, which evaluate the 15 
magnitude of treatment effect
25
. The formula Cohen's dz was used (mean change score divided by 16 
the standard deviation of change), as this is the effect size index recommended for matched pairs
26
. 17 
Cohen’s dz for each outcome measure was calculated using the G*Power 3 software (University 18 
Düsseldorf, Germany) and was interpreted as a small (≥0.2), medium (≥0.5) or large (≥0.8) effect
27
.  19 
Results 20 
Thirty patients enrolled in the study, however 4 (13.3%) dropped-out due to overlap between the 21 
program schedule and professional activities (n=1), relocation (n=1), respiratory exacerbation (n=1) 22 
and no reason given (n=1). Therefore, 26 participants (16 males; age 67.8±10.3 years old) completed 23 
the study. Table 1 provides the characteristics of the participants. 24 
(insert table 1 about here) 25 
The PR program had no effect on lung function (pre 83.8% predicted vs. post 84.1% predicted; 
26 
p=0.73) (table 2). A reduction in participants’ dyspnea was observed (pre median [interquarlile range] 
27 
1[1,2] vs. post 1[0,1]; p=0.003; ES=0.7), with more than half of participants (n=16; 61.5%) presenting 
28 
a mMRC variation >1. Significant improvements were also verified on functional balance (pre 7.8s vs. 
29 
6.7s; p<0.001), muscle strength (shoulder flexors pre 2.3kg vs. post 3.6kg; knee extensors pre 4.1kg 
30 
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vs. post 6.7kg; p<0.001) and exercise tolerance (pre 432m vs. post 464m; p<0.001), with medium and 
1 
large effects sizes (from 0.5 to 1.3) (table 2). However, no differences were found for the emotional 
2 
states of depression (pre median 6 vs. post 4; p=0.65), anxiety (pre median 6 vs. post 5; p=0.82) and 
3 
stress (pre median 10 vs. post 8; p=0.63). The SGRQ total score (pre 31.3 vs. post 25; p=0.005; 
4 
ES=0.3), the SGRQ symptoms score (pre 46.3 vs. post 34.7; p<0.001; ES=0.6) and the SGRQ 
5 
activities score (pre 44 vs. post 34.8; p=0.02; ES=0.4) improved significantly after PR, reaching the 
6 
MID (4 units)
21
. However, there was no significant improvement on the SGRQ impact score (pre 19.4 
7 
vs. post 16.3; p=0.14). 
8 
(insert table 2 about here) 9 
Discussion 10 
According to our knowledge, this was the first study to investigate the effects of PR on different health 11 
domains in patients with mild COPD. The main finding was that a 12-week PR program was effective 12 
in improving patients’ dyspnea, functional balance, muscle strength, exercise tolerance and HRQL. 13 
A perceived clinical improvement on dyspnea was observed in >50% of patients, in line with the 14 
existing evidence on the benefits of PR in patients with moderate-to-very-severe COPD
12
. This result 15 
demonstrates that patients with mild COPD already experience restrictions in their daily life due to 16 
dyspnea and that PR has the potential to reverse this situation. Regarding the effect of the program 17 
on patients’ functional balance, a change of -1.1±1 seconds on TUG score was found. This change is 18 
lower than that obtained by Beauchamp et al. (-1.5±2.4 seconds), which examined the effect of a 19 
standard PR program on balance of patients with more severe COPD grades (mean FEV1 20 
46.3±22.3%)
28
. However, this result is not surprising since patients with mild COPD had better 21 
baseline scores compared with patients included in the previous mentioned study, and thus less 22 
potential to further improve their functional balance was expected. Increases of 56.5% on shoulder 23 
flexors and of 63.4% on knee extensors muscle strength were verified. These results are difficult to 24 
interpret in the absence of published MID values for the 10-RM. Nevertheless, the percentage 25 
changes found are similar to previous research (a 56.3% increase in chest pull exercise and 88.2% in 26 
leg extension)
29
. 27 
The improvement in the distance walked after PR was about 32 meters. Considering that 25 meters is 28 
the MID for the 6MWT in patients with COPD
18
, it could be assumed that this study achieved the 29 
clinically important effect. However, this MID was established based on a sample of patients with a 30 
Page 19 of 26 Respiratory Care
For Peer Review
8 
 
wide range of disease severity and may not represent a clinically important effect for patients with 1 
mild COPD. Future studies should determine the MID for the 6MWT in patients with mild COPD to 2 
contribute for clinical decision-making in this COPD population. 3 
An improvement in the SGRQ total score of about 6 units was also observed, exceeding the 4 units 4 
considered clinically relevant
21
. This result demonstrates that HRQL in patients with mild COPD, even 5 
if not severely affected (baseline scores of 31.3 in 100), can be improved with PR. Contrary to the 6 
symptoms and activities domains, the impact domain was not significantly different after PR. Patients 7 
with mild COPD might not experience yet relevant disturbances in social and psychological 8 
functioning in their daily life, demonstrated by the low impact scores found at baseline (19.4 in 100)
5
, 9 
and therefore this domain had less potential to be improved. 10 
The PR program had no effect on lung function, which is in accordance with the short-term effects of 11 
PR
30
. However, a longitudinal study with patients with moderate-to-severe COPD showed that, after 12 
three years, the decline in FEV1 was significantly lower in the PR group compared to the standard 13 
care group
31
. The potential of PR in delaying the decline of lung function should therefore be 14 
examined in patients with mild COPD as well. Patients’ emotional state also did not improve after the 15 
intervention. However, significant benefits in the emotional function of patients with moderate-to-very-16 
severe COPD after PR programs have been described
2
. Since patients’ baseline scores on DASS 17 
were only slightly higher than normative values (depression 6 vs. 2; anxiety 6 vs. 2; stress 10 vs. 8)
20
, 18 
one possible reason for this result may be that patients with mild COPD may not yet experience 19 
significant emotional distress. 20 
The overall findings suggest that PR is effective in improving dyspnea, functional balance, muscle 21 
strength, exercise tolerance and HRQL in patients with mild COPD. Thus, the critical question for 22 
future studies should move from “should patients with mild COPD be integrated in PR?” to “how 23 
should PR be delivered to these patients?”. Since patients are not referred to hospital-based PR 24 
programs until they have advanced COPD
1
, less expensive and complex PR programs available at 25 
primary care centers could be a promising strategy to deliver PR to patients with mild COPD. These 26 
programs, through the exercise training component, would maintain patients at higher levels of 27 
function. Exercise programs in fitness centers with adequate supervision by trained professionals 28 
would probably accomplish the same physical benefits of these simple PR programs, with fewer 29 
costs; however these programs do not address patients’ education and behavior change needs. The 30 
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psychoeducation component of PR through collaborative self-management strategies, increases 1 
patients’ knowledge and skills, key aspects to optimally manage their disease. Therefore, the potential 2 
of primary-care based PR to modify the COPD trajectory in patients at earlier grades should be 3 
investigated in future COPD research. 4 
This study has some limitations that need to be acknowledged. The absence of a control group is a 5 
limitation of this exploratory study. However, as no research has been conducted on this topic, this 6 
limitation does not appear to remove the validity and importance of the results found. In future studies, 7 
a control group with patients with similar socio-demographic and clinical characteristics should be 8 
included. A small sample size was estimated to be sufficient to detect statistically significant 9 
differences in the 6MWT, however a larger sample would probably contribute to detect statistically 10 
significant differences in the other outcome measures collected, such as DASS and SGRQ impact 11 
score. Nonetheless, data from these outcome measures may inform the estimation of sample sizes in 12 
future studies. Moreover, the evaluators in this study were the same health professionals that 13 
delivered the PR program, which may have influenced the way that outcome measures were 14 
assessed. Due to the cross-sectional design, the long-term effects of PR on mild COPD could not be 15 
established. Blind randomized control trials with long-term follow-ups are therefore needed. 16 
Conclusion 17 
The PR program was effective in improving dyspnea, functional balance, muscle strength, exercise 18 
tolerance and HRQL of patients with mild COPD, suggesting that these patients would benefit of 19 
being routinely included in PR programs. Studies with more robust designs and with long-term follow-20 
ups are needed to inform guidelines for PR in mild COPD. 21 
 22 
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Table 1- Socio-demographic and clinical characteristics of the participants (n=26). 1 
Characteristics  Result 
Age (yrs) 67.8±10.3 
Male 16(59.3%) 
BMI (kg/m
2
) 28.7±5.01 
Smokers 7(25.9%) 
Exacerbations past 3 
months 
 
   0 14(53.9%) 
   1-2 7(26.9%) 
   ≥3 5(19.2%) 
FEV1 (L) 2±0.4 
FEV1 (% predicted) 83.8±5.4 
Note: values show mean±SD or n(%) unless otherwise indicated. Abbreviations: BMI, body 2 
mass index; FEV1, forced expiratory volume in 1 second. 3 
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Table 2 - Effect of PR on lung function, dyspnea, functional balance, muscle strength, exercise 1 
tolerance, emotional state and health-related quality of life (n=26). 2 
Variable Pre-PR Post-PR p-
value 
ES 
FEV1% predicted 83.8±6.4 84.1±5.4 0.73† 0 
mMRC 1[1, 2] 1[0, 1] 0.003
‡
 0.7 
TUG score (s) 7.8±1.5 6.7±1.2 <0.001† 0.8 
10-RM shoulder flexors strength 
(kg) 
2.3±0.9 3.6±1.2 <0.001† 1.2 
10-RM knee extensors strength 
(kg) 
4.1±2.1 6.7±1.9 <0.001† 1.3 
6MWD (m) 432±76 464±76 <0.001† 0.5 
DASS-Depression 6[1.5, 9] 4[0.5, 8] 0.65
‡
 0.2 
DASS-Anxiety 6[1.5, 12] 5[2, 10] 0.82
‡
 0 
DASS-Stress 10[5.5, 16] 8[4, 15] 0.63
‡
 0 
SGRQ total score 31.3±18.5 25±17.8 0.005† 0.3 
SGRQ symptoms score 46.3±20.2 34.7±21.4 <0.001† 0.6 
SGRQ activities score 44±25.2 34.8±24.3 0.02† 0.4 
SGRQ impact score 19.4±17.9 16.3±15.4 0.14† 0.2 
Note. Values show as mean±SD or Median[interquarlile range]; † paired t-test; 
‡
 Wilcoxon signed-rank 3 
test. Abbreviations: ES, effect sizes; FEV1, forced expiratory volume in 1 second; mMRC, Modified 4 
British Medical Research Council questionnaire; TUG, Timed up and go; 10-RM, 10 repetition 5 
maximum; 6MWD, 6-minute walking distance; DASS, Depression, Anxiety and Stress Scale;  SGRQ, 6 
St. George’s Respiratory Questionnaire. 7 
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